NSE filing, NSE: SARTELE. Summary written from the filing by ALFA Finder's alert engine.
SAR Televenture Ltd: key numbers
- Share price
- ₹78.90
- Market cap
- ₹395.7 Cr
- Revenue (annual)
- ₹522.1 Cr
- Net profit (annual)
- ₹71.82 Cr
- P/E (TTM)
- 5.5×Sector 36.9×
- Promoter holding
- 45.53%
- FII holding
- 2.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SAR Televenture Ltd
All →SAR Televenture Annual General Meeting
Sar Televenture seeks approval to sell 90.82% of Fusionnet to Tikona Communication for Rs 256.84 Crore. The sale consolidates group telecom operations.
- Value
- ₹256.8 Cr
SAR Televenture Merger & Restructuring Worth ₹256.8 Cr
Sar Televenture Limited approved the divestment of its 90.82% stake in subsidiary Fusionnet Web Services Limited to Tikona Communication Limited for Rs. 256.84 Crore.
- Value
- ₹256.8 Cr
SAR Televenture Annual General Meeting
SAR Televenture Limited held its 7th Annual General Meeting on September 29, 2026, through video conferencing to transact business as set out in the meeting notice.
SAR Televenture Acquisition
SAR Televenture Limited completed its acquisition of 70.17% stake in Tikona Communication Limited. The company has now acquired control and become the promoter of the target.
SAR Televenture Merger & Restructuring
Sar Televenture Limited has cancelled the proposed acquisition of Tikona Infinet Private Limited and withdrawn its related application for a preferential share allotment.
SAR Televenture Other Announcement
The company notified the Exchange regarding its compliance with Regulation 36(1)(b) by sending letters to shareholders with unregistered email addresses for accessing the Annual Report.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.